Bill Ackman on the price drop in Valeant Pharmaceuticals

At this price, it's a gift to investors.

~ Bill Ackman, as appeared on CNBC, July 31, 2014

(Valeant stock was trading at about $120, down from previous close of $125.83.  VRX was selling off after release of Q2 earnings.)